Published in In Vitro on February 01, 1978
Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. J Virol (1984) 1.57
Avian reticuloendotheliosis virus: characterization of the high-molecular-weight viral RNA in transforming and helper virus populations. J Virol (1980) 1.31
Baboon endogenous virus genome. I. Restriction enzyme map of the unintegrated DNA genome of a primate retrovirus. J Virol (1980) 1.13
Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency virus Gag precursor polypeptide. J Virol (1994) 1.06
Analysis of the nucleic acid components in reticuloendotheliosis virus. J Virol (1980) 1.03
Analysis of the virogenes related to the rhesus monkey endogenous type C retrovirus in monkeys and apes. J Virol (1981) 0.91
Synthesis of long complementary DNA in the endogenous reaction by equine infectious anemia virus. J Virol (1979) 0.85
Immunological characterization of the gag gene products of bovine immunodeficiency virus. J Virol (1992) 0.84
DNA sequence relationship of the baboon endogenous virus genome to the genomes of other type C and type D retroviruses. J Virol (1982) 0.83
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Streptococcus salivarius. J Bacteriol (1937) 10.70
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res (1988) 9.96
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature (1985) 5.41
THE THERMOPHILIC AND ANAEROBIC NATURE OF LACTOBACILLUS BULGARICUS. Science (1936) 4.18
New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst (1989) 4.04
Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor. J Exp Med (1984) 2.00
Development of human tumor cell line panels for use in disease-oriented drug screening. Prog Clin Biol Res (1988) 1.95
Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures. J Natl Cancer Inst (1974) 1.62
In vitro system for production of mouse mammary tumor virus. Appl Microbiol (1974) 1.54
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J Natl Cancer Inst (1975) 1.44
Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins. Virology (1978) 1.35
Isolation and characterization of an endogenous type C virus of rhesus monkeys. Science (1979) 1.32
Propagation of mouse mammary tumor cell lines and production of mouse mammary tumor virus in a serum-free medium. In Vitro (1976) 1.18
The Value of Certain Tests in the Differentiation of Lactobacillus bulgaricus from Lactobacillus acidophilus. J Bacteriol (1940) 1.09
Immunological characterization of the low-molecular-weight DNA binding protein of mouse mammary tumor virus. Int J Cancer (1978) 1.06
Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent. Proc Natl Acad Sci U S A (1985) 1.04
Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence. Cancer Res (1976) 0.98
Adaptation and infection of mouse bone marrow (JLS-V9) cells in suspension culture for production of Rauscher leukemia virus. Appl Microbiol (1974) 0.97
Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res (1988) 0.97
In vitro host range of equine infectious anemia virus. Intervirology (1981) 0.97
Rat sarcoma virus: further analysis of individual viral isolates and the gene product. J Virol (1981) 0.96
Coexistence of the mouse mammary tumor virus (MMTV) major glycoprotein and natural antibodies to MMTV in sera of mammary tumor-bearing mice. Virology (1978) 0.96
Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Cancer Res (1976) 0.96
Differentiation of Trichoplusia ni MEV and Autographa californica MEV by macrophage migration inhibition tests. J Invertebr Pathol (1973) 0.95
Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice. J Virol (1979) 0.95
Naturally occurring humoral immunity to murine mammary tumor virus (MuMTV) and MuMTV GP52 in mice with low mammary tumor incidence. Int J Cancer (1978) 0.92
Mouse mammary tumor virus and murine leukemia virus cell surface antigens on virus producer and nonproducer mammary epithelial tumor cells. Virology (1978) 0.88
Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates. J Virol (1978) 0.87
Growth of chikungunya virus in baby hamster kidney cell (BHK-21-clone 13) suspension cultures. Appl Microbiol (1971) 0.87
Simian tumor virus isolate: demonstration of cytopathic effects in vitro. Science (1971) 0.86
Host-cell lysosomal response to two strains of herpes simplex virus. J Virol (1970) 0.86
Direct syncytial assay for the quantitation of bovine leukemia virus. Infect Immun (1978) 0.85
Squirrel monkey retrovirus: electron microscopy of a virus from New World monkeys and comparison with Mason-Pfizer monkey virus. Arch Virol (1978) 0.84
Cell culture factors influencing in vitro expression of mouse mammary tumor virus. In Vitro (1976) 0.82
Surface localization of virus production on a glucocorticoid-stimulated oncornavirus-producing mouse mammary tumor cell line by scanning electron microscopy. Cancer Res (1976) 0.80
Expression of natural antibodies against endogenous and horizontally transmitted macaque retroviruses in captive primates. Virology (1981) 0.80
Characterization of infection and replication of Mason-Pfizer monkey virus in human cell cultures. J Gen Virol (1979) 0.80
Oncogenicity of murine mammary tumor virus produced in tissue culture: brief communication. J Natl Cancer Inst (1978) 0.80
Type B and type C RNA tumor virus replication in single cells. Electron microscopy with tannic acid. J Natl Cancer Inst (1978) 0.79
Studies with equine infectious anemia virus: transmission attempts by mosquitoes and survival of virus on vector mouthparts and hypodermic needles, and in mosquito tissue culture. Am J Vet Res (1981) 0.79
Large-scale production of mouse mammary tumor virus in the absence of endogenous murine leukemia virus. Appl Environ Microbiol (1979) 0.79
Species- and genus-specific antigenic determinants of simian agent 12 VP1 as defined with monoclonal antibodies. Virology (1982) 0.79
Biologic characteristics of transformed rhesus foreskin cells infected with Mason-Pfizer monkey virus. J Natl Cancer Inst (1974) 0.78
Monoclonal antibodies as immunospecific probes for virus and cell surface antigen localization with the unlabeled antibody hemocyanin bridge: a review. Scan Electron Microsc (1981) 0.78
Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice. J Natl Cancer Inst (1978) 0.78
Transformation of rhesus foreskin cells by Mason-Pfizer monkey virus. J Natl Cancer Inst (1972) 0.78
Type D retroviruses: occurrence of natural antibodies to Mason-Pfizer monkey virus in rhesus monkeys. Virology (1978) 0.77
Features of cross protection between Sindbis and Venezuelan equine encephalitis viruses in mice--relationship of route of immunization to protection. J Gen Virol (1974) 0.77
Virus susceptibility of a new simian cell line of fetal origin. Appl Microbiol (1973) 0.77
Some genetic aspects of the resistance of Spodoptera frugiperda to a nuclear polyhedrosis virus. J Invertebr Pathol (1974) 0.76
Natural distribution of squirrel monkey retrovirus proviral sequences in primate DNAs. J Gen Virol (1978) 0.75
Contributions of the founders of Craig Colony to epileptology and public care of epileptics: 1890-1915. J Hist Neurosci (1995) 0.75
Simian tumour virus proliferation in inoculated Macaca mulatta. Nat New Biol (1972) 0.75
Immunological relationship between an oncornavirus isolate from HEp-2 cells, Mason-Pfizer monkey virus, and human tumor cells. Bibl Haematol (1975) 0.75
Functionally conserved determinants on gp70s of endogenous primate retroviruses. Virology (1980) 0.75
William P. Letchworth: philanthropist and pioneer epileptologist. Arch Neurol (1993) 0.75
Demonstration of components of serum-free culture medium effecting maximum in vitro expression of mouse mammary tumor virus. In Vitro (1978) 0.75
The contributions of Dr. Roswell Park to epilepsy and spinal surgery. Neurosurgery (1998) 0.75
Three state health reform initiatives fail. Health Syst Rev (1994) 0.75
Mason-Pfizer monkey virus and simian AIDS. Lancet (1984) 0.75
Development of herpes simplex virus in the isolated nuclei of HEp-2 cells. I. Viability of isolated HSV-infected nuclei. Can J Microbiol (1972) 0.75
The importance of Spratling. Arch Neurol (1994) 0.75
Development of herpes simplex virus in the isolated nuclei of HEp-2 cells. II. Intranuclear events in isolated HSV-infected nuclei. Can J Microbiol (1972) 0.75
A genus-specific radioimmunoassay for simian virus 40-polyoma viruses. Intervirology (1981) 0.75